Content about Branded

January 4, 2011
Endo's Fortesta receives FDA approval

The Food and Drug Administration has approved a topical testosterone replacement therapy made by Endo Pharmaceuticals, Endo said last week.

January 4, 2011
Pfizer inks deal with Santaris

Pfizer will pay Danish biotech company Santaris Pharma $14 million for access to its development platform for RNA-based therapies, Pfizer said Tuesday.

January 3, 2011
Drug approvals low in 2010

This past year saw a lower-than-usual number of new drugs approved by the Food and Drug Administration, due in part to delays at the agency, according to published reports.

January 3, 2011
George W. Bush to deliver keynote speech at Armada summit

Former president George W. Bush will deliver the keynote speech at Armada Health Care’s seventh annual Armada Specialty Pharmacy Summit, the specialty pharmacy contracting organization said.

January 3, 2011
New strength of Intelence gets regulatory approval

The Food and Drug Administration has approved an update to the label of a Johnson & Johnson drug for HIV, the company said Monday.

December 29, 2010
FDA rejection of lower-dose Copaxone will likely ward off generic competition

Recent news that the FDA has rejected Teva's application for a new lower-dose version of multiple sclerosis drug Copaxone likely will hold off the emergence of a generic version of the drug.

December 23, 2010
Cephalon appoints new CEO

Cephalon on Thursday appointed Kevin Buchi as CEO and a member of the company's board.

December 23, 2010
FDA approves Merck's Gardasil for prevention of anal cancer

Merck on Wednesday announced that the Food and Drug Administration has approved Gardasil [human papillomavirus quadrivalent (types 6, 11, 16 and 18) vaccine, recombinant] for the prevention of anal cancer in males and females 9 to 26 years of age.

December 23, 2010
FDA approves Novartis drug for high blood pressure treatment

The Food and Drug Administration on Wednesday approved Novartis Pharmaceuticals’ Amturnide (aliskiren, amlodipine and hydrochlorothiazide) tablets for the treatment of high blood pressure, according to the pharma company.

December 23, 2010
FDA approves Watson oral contraceptive

The Food and Drug Administration has approved the first and only low-dose oral contraceptive to combine 0.8-mg norethindrone and 0.025-mg ethinyl estradiol in a chewable form, with four 75-mg ferrous fumarate (iron) placebo tablets, Watson Pharmaceuticals has announced.

December 22, 2010
Takeda settles patent suits relating to Actos

Takeda and its subsidiary settled the patent suits it brought against generic drug makers that sought to develop their own versions of its diabetes treatment.

December 21, 2010
Abbott, EpiTherapeutics ink 3-year licensing agreement

Abbott has made a pact with a biopharmaceutical company to develop new cancer treatments by making small-molecule inhibitors.

December 21, 2010
AstraZeneca discontinues development of RSV drug

An Anglo-Swedish drug maker said it is discontinuing further development of a drug that is designed to prevent a respiratory virus that infects the lungs and breathing passages.

December 21, 2010
Biogen acquires rights to neuro disease programs

In a deal that will bolster its drug development capabilities, Biogen Idec has acquired a subsidiary of Swiss-based Neurimmune Holding AG.

December 21, 2010
Court blocks AstraZeneca's suits over Crestor

A judge recently blocked AstraZeneca from attempting to impede the development of generic versions of its popular cholesterol drug, according to published reports.

December 21, 2010
Lilly completes acquisition of Avid

One month after announcing it would acquire a leader in molecular imaging development, Eli Lilly announced it has completed its acquisition of Avid Radiopharmaceuticals.

December 21, 2010
Novo Nordisk, Emisphere enter insulin deal

A biopharmaceutical company exclusively will develop and commercialize oral formulations of a drug maker's insulins.

December 21, 2010
Pfizer to recall lot of Lipitor

Pfizer on Monday announced that it intends to recall one lot — approximately 19,000 bottles — of Lipitor 40-mg tablets (atorvastatin calcium) distributed in the United States because of one customer’s report of an uncharacteristic odor related to the bottles in which these lots of Lipitor were packaged.

December 21, 2010
URAC revises accreditation programs

A healthcare accrediting organization is revising three products in its Pharmacy Quality Management suite of programs.

December 20, 2010
Lilly donates grant to Manchester College for pharmacy school

Manchester College has received a $35 million grant from the Lilly Endowment to launch a new school of pharmacy.

December 20, 2010
Valeant names interim CFO

Valeant Pharmaceuticals' former SVP and corporate controller has been appointed to the role of interim CFO.

December 17, 2010
FDA approves Safyral

The Food and Drug Administration has approved a new oral contraceptive developed by Bayer.

December 17, 2010
FDA declines to approve Brilinta

The Food and Drug Administration has turned down AstraZeneca’s regulatory approval application for a drug to treat heart disease, the drug maker said.

December 17, 2010
Frank Baldino, Cephalon leader, dies at 57

Frank Baldino, the founder, chairman and CEO of Cephalon, has died, the company said.

December 16, 2010
Biodel's Steiner to retire, remains board member

A drug maker specializing in the treatment of diabetes announced the retirement of its chief scientific officer.

© 2013 Drug Store News. All Rights Reserved.